“We're not seeing high rates of XBB.1.16 yet in the United States, but it may become more prominent in coming weeks," says Matthew Binnicker, PhD, director of the Clinical Virology Laboratory at Mayo Clinic.
“We're not seeing high rates of XBB.1.16 yet in the United States, but it may become more prominent in coming weeks," says Matthew Binnicker, PhD, director of the Clinical Virology Laboratory at Mayo Clinic.